CRSP CRISPR Therapeutics AG
37,443
$56.22
$0.55
(0.99%)
| Watchers | 37,443 |
| 52-Wk Low | $37.55 |
| 52-Wk High | $91.10 |
| Market Cap | $4.77B |
| Volume | 1.08M |
| 52-Wk High | $91.10 |
| 52-Wk Low | $37.55 |
CRISPR Therapeutics's Options Frenzy: What You Need to KnowBenzinga • about 1 month ago
read more...
Share to Feed
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics...
ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
Investors are always on the lookout for new stocks to buy. We're looking for bargains, high-potential stocks, and dividend giants.
One area of the market that's getting a lot of attention is gene...
Crispr Therapeutics AG (CRSP Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on April 1. Analyst Salim Sy...
ZUG, Switzerland and BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious...
CRISPR Therapeutics (NASDAQ:CRSP) stock has been falling over the past month. Without any milestone announcements since it gained its second U.S. r...
The "it factor." Some stocks have it. Others don't. But when you find stocks with the "it factor," you'll want to load up on them.Three Motley Fool contributors believe they've identified three...
Kingswood Wealth Advisors LLC acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the...
Crispr Therapeutics: Upcoming Catalysts May Validate The Bull Thesis And Force A Change In Plans...